This invention discloses a detection method for
cellular senescence based on the synergistic detection of SA-β-Gal and γH2AX dual biomarkers, belonging to the field of
biotechnology. This invention first performs SA-β-Gal
staining on live cells, then fixes the cells for γH2AX
immunofluorescence labeling, achieving "dual biomarker detection in the same
cell," saving time and reducing sample loss. Through the dual determination of "γH2AX positive (indicating
DNA damage) and SA-β-Gal positive (indicating functional arrest)," this invention significantly improves the specificity and accuracy of
senescent cell identification, reducing the false positive or false negative rate of single biomarkers. It greatly avoids the problems of "missing early
senescence" or "misjudging damaged repair cells" associated with single biomarkers, enabling dynamic tracking of the aging process. Compared to traditional detection methods, this invention uses a non-invasive method, enabling sensitive, efficient, and rapid quantitative and
qualitative analysis of non-fixed senescent cells, breaking through the bottlenecks of traditional detection methods, achieving high specificity, high accuracy, and high compatibility, and can be widely applied in
clinical diagnosis.